Røge R - Search Results

1

Ki-67 Proliferation Index in Breast Cancer as a Function of Assessment Method: A NordiQC Experience.

Røge R, Nielsen S, Riber-Hansen R, Vyberg M. Røge R, et al. Appl Immunohistochem Mol Morphol. 2021 Feb 1;29(2):99-104. doi: 10.1097/PAI.0000000000000846. Appl Immunohistochem Mol Morphol. 2021. PMID: 32168036

2

Carb-3 is the superior anti-CD15 monoclonal antibody for immunohistochemistry.

Røge R, Nielsen S, Vyberg M. Røge R, et al. Appl Immunohistochem Mol Morphol. 2014 Jul;22(6):449-58. doi: 10.1097/PAI.0b013e318292b764. Appl Immunohistochem Mol Morphol. 2014. PMID: 23846425

3

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests.

Vyberg M, Nielsen S, Røge R, Sheppard B, Ranger-Moore J, Walk E, Gartemann J, Rohr UP, Teichgräber V. Vyberg M, et al. Among authors: roge r. BMC Health Serv Res. 2015 Aug 29;15:352. doi: 10.1186/s12913-015-1018-6. BMC Health Serv Res. 2015. PMID: 26318869 Free PMC article.

4

Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.

Røge R, Riber-Hansen R, Nielsen S, Vyberg M. Røge R, et al. Breast Cancer Res Treat. 2016 Jul;158(1):11-19. doi: 10.1007/s10549-016-3852-6. Epub 2016 Jun 9. Breast Cancer Res Treat. 2016. PMID: 27283833

5

Quantitative tumor heterogeneity assessment on a nuclear population basis.

Wessel Lindberg AS, Conradsen K, Larsen R, Friis Lippert M, Røge R, Vyberg M. Wessel Lindberg AS, et al. Among authors: roge r. Cytometry A. 2017 Jun;91(6):574-584. doi: 10.1002/cyto.a.23047. Epub 2017 Jan 31. Cytometry A. 2017. PMID: 28141908 Free article.

6

NordiQC Assessments of SOX10 Immunoassays.

Røge R, Nielsen S, Bzorek M, Vyberg M; ISIMM-NordiQC Immunoassay Performance Assessment Series, No. 1. Røge R, et al. Appl Immunohistochem Mol Morphol. 2017 Jul;25(6):377-380. doi: 10.1097/PAI.0000000000000536. Appl Immunohistochem Mol Morphol. 2017. PMID: 28549040

7

Accurate PD-L1 Protocols for Non-Small Cell Lung Cancer can be Developed for Automated Staining Platforms With Clone 22C3.

Røge R, Vyberg M, Nielsen S. Røge R, et al. Appl Immunohistochem Mol Morphol. 2017 Jul;25(6):381-385. doi: 10.1097/PAI.0000000000000534. Appl Immunohistochem Mol Morphol. 2017. PMID: 28697065

8

NordiQC Assessments of Low Molecular Weight Keratin 8/18 Immunoassays.

Vyberg M, Diernæs C, Røge R, Nielsen S; ISIMM-NordiQC Immunoassay Performance Assessment Series, No. 2. Vyberg M, et al. Among authors: roge r. Appl Immunohistochem Mol Morphol. 2017 Nov/Dec;25(10):673-678. doi: 10.1097/PAI.0000000000000603. Appl Immunohistochem Mol Morphol. 2017. PMID: 29116958

9

NordiQC Assessments of PAX8 Immunoassays.

Røge R, Nielsen O, Bzorek M, Nielsen S, Vyberg M. Røge R, et al. Appl Immunohistochem Mol Morphol. 2018 Apr;26(4):221-224. doi: 10.1097/PAI.0000000000000651. Appl Immunohistochem Mol Morphol. 2018. PMID: 29621095

10

NordiQC Assessments of MSH6 Immunoassays.

Vyberg M, Røge R, Bzorek M, Nielsen O. Vyberg M, et al. Among authors: roge r. Appl Immunohistochem Mol Morphol. 2018 Aug;26(7):431-434. doi: 10.1097/PAI.0000000000000681. Appl Immunohistochem Mol Morphol. 2018. PMID: 30024425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters